Objective:

To summarize current data on how hormonal changes during pregnancy contribute to bone fragility and the condition known as Pregnancy and Lactation-Associated Osteoporosis (PLO).

Approach:

Key Findings:

• Add information about the placenta's role in bone remodeling.

Interpretation:

Expand to include implications for maternal health and potential treatment strategies.

Limitations:

• Specify the need for studies on hormone interactions with skeletal cells.

Conclusion:

Suggest specific areas for future research on PLO and hormonal influences.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.